SAN DIEGO--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: “ZURA”) (“Zura” or “Zura Bio”), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and ...
Medium- and heavy-duty commercial vehicle production improved steadily throughout 2022, and OEMs have been building at essentially full capacity in 2023. Sales, order, and backlog trends are covered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback